ABBLO PHARMA ApS Financials, key figures and credit report
Gross profit 471.9 kDKK FY 2025 -44.8% vs 2024
EBIT 31.1 kDKK FY 2025 -90.8% vs 2024
Net debt 413.8 kDKK FY 2025 -1.7% vs 2024
Quick ratio 1.7 FY 2025 -0.4 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 740.46 | 1 056.15 | 1 020.51 | 854.99 | 471.87 |
| Employee benefit expenses | - 424.93 | - 698.59 | - 614.49 | - 516.94 | - 440.72 |
| EBIT | 315.53 | 357.56 | 406.02 | 338.05 | 31.15 |
| Other financial income | 19.95 | 19.34 | 14.33 | 3.67 | 19.25 |
| Other financial expenses | -50.24 | -76.13 | - 312.97 | - 206.50 | - 202.66 |
| Pre-tax profit | 285.24 | 300.77 | 107.38 | 135.22 | - 152.26 |
| Net earnings | 285.24 | 300.77 | 107.38 | 135.22 | - 152.26 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 348.22 | 498.49 | 287.94 | 323.82 | 290.44 |
| Inventories total | 348.22 | 498.49 | 287.94 | 323.82 | 290.44 |
| Current trade debtors | 338.88 | 451.50 | 548.94 | 498.45 | 375.11 |
| Current other receivables | 8.89 | 1.71 | 8.11 | 9.49 | |
| Short term receivables total | 347.77 | 451.50 | 550.65 | 506.56 | 384.60 |
| Cash and bank deposits | 186.26 | 211.70 | 629.75 | 542.27 | 486.15 |
| Cash and cash equivalents | 186.26 | 211.70 | 629.75 | 542.27 | 486.15 |
| Balance sheet total (assets) | 882.25 | 1 161.69 | 1 468.34 | 1 372.65 | 1 161.19 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 80.00 | 80.00 | 80.00 | 80.00 | 80.00 |
| Retained earnings | - 994.43 | - 709.19 | - 408.42 | - 301.04 | - 165.83 |
| Profit of the financial year | 285.24 | 300.77 | 107.38 | 135.22 | - 152.26 |
| Shareholders equity total | - 629.19 | - 328.42 | - 221.04 | -85.83 | - 238.09 |
| Non-current owed to group member | 933.87 | 922.98 | 889.18 | 963.16 | 900.00 |
| Non-current liabilities total | 933.87 | 922.98 | 889.18 | 963.16 | 900.00 |
| Current trade creditors | 232.19 | 182.90 | 342.06 | 228.47 | 344.29 |
| Other non-interest bearing current liabilities | 345.38 | 384.23 | 458.15 | 266.86 | 155.00 |
| Current liabilities total | 577.57 | 567.14 | 800.20 | 495.32 | 499.28 |
| Balance sheet total (liabilities) | 882.25 | 1 161.69 | 1 468.34 | 1 372.65 | 1 161.19 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated